๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Vasculitis

A Randomized Multicenter Study for Isolated Skin Vasculitis NCT02939573Phase 216 sites๐Ÿ“ Kansas City๐Ÿ“ Boston๐Ÿ“ Rochester University of Pennsylvania ยท Tests: Colchicine, Dapsone, Azathioprine MEMRI and Kidney Disease NCT06698614n/a1 site๐Ÿ“ Edinburgh University of Edinburgh ยท Tests: MRI, Blood tests, Urine tests, Cardiovascular analysis Diet Restiction in Subjects With Behcet Disease and Complaint of Tinnitus NCT07702149NA2 sites๐Ÿ“ Giza๐Ÿ“ Dokki Cairo University ยท Tests: diet restriction The Use of Machine Learning Techniques for the Differential Diagnosis Between Eosinophilic Granulomatosis With Polyangiitis and Hypereosinophilic Syndrome NCT07275190NA1 site๐Ÿ“ Pavia Fondazione IRCCS Policlinico San Matteo di Pavia ยท Tests: Blood draw for the laboratory assessment Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases. NCT06581562Phase 11 site๐Ÿ“ Plantation IRIS Research and Development, LLC ยท Tests: AB-101, Rituximab, Cyclophosphamide, Fludarabine A Multicenter Phase 2 Single-arm Proof-of-concept Trial Assessing the Efficacy and Safety of Obinutuzumab in the Treatment of Non-infectious Active Cryoglobulinemia Vasculitis Refractory or Intolerant to Rituximab NCT07268521Phase 225 sites๐Ÿ“ Blois๐Ÿ“ Bondy๐Ÿ“ Bordeaux Assistance Publique - Hรดpitaux de Paris ยท Tests: Obinutuzumab A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases. NCT07203404EARLY Phase 11 site๐Ÿ“ Shanghai Nanjing Bioheng Biotech Co., Ltd. ยท Tests: RD06-05 CART Cell Injection An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease NCT06379646NA1 site๐Ÿ“ Shanghai China Immunotech (Beijing) Biotechnology Co., Ltd. ยท Tests: YTS109 Global Initiative on Takayasu Arteritis (GITA) NCT07558382n/a2 sites๐Ÿ“ Istanbul๐Ÿ“ Istanbul Marmara University Evaluation of Proximal Massage and Palm-to-Fist Tapping on Reducing the Risk of Phlebitis NCT07703618NA1 site๐Ÿ“ Bogotรก Hospital Universitario San Ignacio ยท Tests: Estandard peripheral venous catheter care protocol, Efecto del masaje proximal y del golpeteo de la palma al puรฑo. Rare AutoImmune SElf-management Programme Development NCT06642870n/a1 site๐Ÿ“ Bristol University of the West of England ยท Tests: Non-interventional study Genome Analysis of Human Endogenous Retroviruses (HERVs)(COVID19) NCT06775457NA5 sites๐Ÿ“ Carpi๐Ÿ“ Bologna๐Ÿ“ Modena IRCCS Azienda Ospedaliero-Universitaria di Bologna ยท Tests: sample collection Prospective Registry of Eosinophilia With Respiratory Manifestations With Translational Research Identifying and Characterizing Eosinophils NCT04538937n/a1 site๐Ÿ“ Innsbruck Medical University Innsbruck ยท Tests: no intervention Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases NCT06775912EARLY Phase 11 site๐Ÿ“ Lianyungang Nanjing Bioheng Biotech Co., Ltd. ยท Tests: RD06-05 CART Cell Injection Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE) NCT06350110Phase 1, Phase 21 site๐Ÿ“ Beijing Essen Biotech ยท Tests: CD19- BCMA CAR-T cells CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases NCT06941129Phase 11 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: UCAR T-cell Giant Cell Arteritis - Ways to Precision Medicine NCT07084480n/a1 site๐Ÿ“ Wรผrzburg Wuerzburg University Hospital Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis NCT02257866n/a1 site๐Ÿ“ Bethesda National Institute of Arthritis and Musculoskeletal and Skiโ€ฆ A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases NCT06512883Phase 315 sites๐Ÿ“ Aurora๐Ÿ“ Cincinnati๐Ÿ“ Highland Hills AstraZeneca ยท Tests: Benralizumab Safety and Efficacy of Universal CD19-targeting CAR-ฮณฮดT Cells in Refractory Autoimmune Diseases NCT06828042Phase 1, Phase 21 site๐Ÿ“ Beijing Peking University Third Hospital ยท Tests: anti-CD19 CAR T cell therapy Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases NCT06685042Phase 1, Phase 21 site๐Ÿ“ Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS ยท Tests: CAR T cell Benralizumab Effectiveness in EGPA NCT07815886n/a1 site๐Ÿ“ Florence European EGPA Study Group ยท Tests: Benralizumab 30 mg/ml Assessing Biomarker in Giant Cell Arteritis and Polymyalgia Rheumatic NCT06460142n/a1 site๐Ÿ“ Bonn University of Bonn ยท Tests: Aortic/ cardiac magnetic resonance imaging, Vascular ultrasound, Transorbital Ultrasound, Contrast-Enhanced Ultrasound,โ€ฆ Abatacept for the Treatment of Giant Cell Arteritis NCT04474847Phase 310 sites๐Ÿ“ Rochester๐Ÿ“ New York๐Ÿ“ Cleveland University of Pennsylvania ยท Tests: Abatacept, Placebo CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases NCT07315087Phase 11 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: QT-019C A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2) NCT06733935Phase 1, Phase 218 sites๐Ÿ“ Orange๐Ÿ“ Gainesville๐Ÿ“ Miami Nkarta, Inc. ยท Tests: NKX019, Fludarabine, Cyclophosphamide Predictive Factors for Treatment Response in Patients With Newly-diagnosed Polymyalgia Rheumatica and Giant Cell Arteritis NCT05479448n/a1 site๐Ÿ“ Basel University Hospital, Basel, Switzerland ยท Tests: Data collection for cellular analyses (Immune subset composition, GCR expression, in vitro steroid responsiveness), Datโ€ฆ BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases NCT06794008Phase 21 site๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: BCMA-CD19 CAR-T therapy A Clinical Trial to Investigate 18F-AzaFol in the Diagnosis of Large Vessel Vasculitis NCT06335888Phase 21 site๐Ÿ“ Bern Insel Gruppe AG, University Hospital Bern ยท Tests: AzaFol, FDG A Real-World Registry of Chronic Wounds and Ulcers NCT02280733n/a1 site๐Ÿ“ The Woodlands U.S. Wound Registry ยท Tests: Usual care
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy